Categories: Business

Cosn Group Appoints Susan Gilmartin as President and Chief Operating Officer and Paul Bockmore as Executive Vice President of Sales

CLEVELAND–(BUSINESS WIRE)–Cosán Group, a leader in delivering virtual care at home, today announced the appointment of Susan Gilmartin as President and Chief Operating Officer and Paul Bockmore as Executive Vice President of Sales.

- Advertisement -


- Advertisement -

Gilmartin brings more than 25 years of executive leadership in healthcare, technology, and private equity-backed businesses. She has overseen nationwide clinical operations, including networks of healthcare professionals delivering in-home care, virtual consultations, and call-center services. Most recently, she served as President at Momentive Software, where she led successful organizational transformation and growth.

- Advertisement -

As President and COO, Gilmartin will lead day-to-day operations, scale execution across the business, and drive alignment as Cosán enters its next phase of growth. “I am honored to join Cosán Group at such an exciting time,” said Gilmartin. “I look forward to working with this talented team to strengthen alignment and accelerate the company’s mission of transforming virtual care.”

- Advertisement -

Bockmore joins as Executive Vice President of Sales, overseeing sales and client service strategy to enhance provider partnerships. He brings more than a decade of experience in the neuromodulation and medical device industry with expertise in sales management, operations, and marketing. Previously, he led the Member Development team at Specialty Networks, supporting over 875 practices, 4,000 physicians, and countless patients through strategic initiatives.

- Advertisement -

“Cosán’s commitment to proactive chronic disease management throughout an individual’s healthcare journey truly resonates with me,” said Bockmore. “I am excited to strengthen partnerships and deliver results for providers and patients alike.”

- Advertisement -

CEO David Hunt welcomed the appointments, saying: “We are thrilled to add Susan and Paul to our leadership team. Their proven track records in healthcare and business transformation will be instrumental as we expand our impact and deliver innovative virtual care solutions.”

- Advertisement -

About Cosán Group

- Advertisement -

Cosán delivers virtual care at home by combining AI-powered automation with human-led care teams. We simplify the complex, connect care plans, reduce fragmentation, and support patients so they can follow protocols between office visits and beyond.

- Advertisement -

Contacts

- Advertisement -

Media Contact:
David Magrini

Chief Marketing Officer

david.magrini@cosangroup.com
860.810.9268

- Advertisement -
Business Wire

Recent Posts

Poppulo Becomes First Employee Comms and Digital Signage Company to Achieve Benchmark ISO Certification for Responsible AI

DENVER and CORK, Ireland, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Poppulo, a global leader in…

24 minutes ago

Syncron Recognized as a Major Player in IDC MarketScape for Worldwide AI-Enabled Aftermarket/Service Life-Cycle Management Platforms

STOCKHOLM, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Syncron, a global leader in intelligent aftermarket Service…

24 minutes ago

The Institute of Technical Education, Singapore, Officially Opens Next-Generation Hybrid Learning Space with X2O Media’s OneRoom

MONTRÉAL, Oct. 1, 2025 /PRNewswire/ -- The Institute of Technical Education (ITE) last month celebrated…

1 hour ago

China International Online Literature Week Opens in Hangzhou, Highlighting an AI-Driven Future

BEIJING, Oct. 1, 2025 /PRNewswire/ -- A news report from China Global Television Network Corporation:…

1 hour ago

New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk

MELBOURNE, Australia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions…

8 hours ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 01, 2025 17:20 ET  | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Oct. 01, 2025 (GLOBE…

8 hours ago